← Doximity, Inc.
| Annual Trend | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| Net income | $29.7m |
$50.2m
+68.85%
|
$154.8m
+208.27%
|
$112.8m
-27.11%
|
$147.6m
+30.81%
|
$223.2m
+51.23%
|
$196.1m
-12.16%
|
$167.0m
-14.79%
|
|
| Depreciation and amortization | $900k | $3.7m | $5.0m | $10.3m | $10.3m | $10.7m | $14.4m | $15.9m | |
| Amortization of deferred contract costs | $5.1m | $6.9m | $9.8m | $8.8m | $8.9m | $10.0m | $13.5m | — | |
| Deferred income taxes | ($7.1m) | $5.0m | ($41.2m) | $13.2m | ($8.6m) | ($11.6m) | $32.1m | $32.1m | |
| Stock-based compensation, net of amounts capitalized | $2.4m | $7.3m | $31.4m | $47.8m | $51.1m | $72.4m | $121.6m | $136.5m | |
| Capitalized stock-based compensation for internal-use software development costs | $184k | $195k | $497k | $865k | $1.1m | $1.8m | $3.6m | — | |
| Impairment of long-lived assets | — | — | — | $0 | $0 | $2.3m | $0 | — | |
| Accounts receivable | ($12.0m) | ($20.5m) | ($31.0m) | ($26.2m) | $4.0m | ($27.2m) | ($16.9m) | ($36.8m) | |
| Accounts payable, accrued expenses and other liabilities | $5.1m | $7.3m | $8.7m | ($195k) | $8.3m | ($663k) | $4.3m | $2.0m | |
| Deferred revenue | $13.3m | $38.6m | $1.8m | $17.5m | ($6.1m) | $15.2m | ($8.1m) | — | |
| Other | $0 | ($12k) | $595k | $0 | $0 | $270k | $314k | — | |
| Prepaid expenses and other assets | ($3.0m) | ($1.8m) | ($9.1m) | ($3.4m) | ($20.5m) | $2.8m | ($8.3m) | — | |
| Net cash provided by operating activities | $26.2m |
$83.0m
+216.70%
|
$126.6m
+52.55%
|
$179.6m
+41.89%
|
$184.1m
+2.50%
|
$273.3m
+48.44%
|
$326.5m
+19.47%
|
$306.3m
-6.16%
|
|
| Purchases of property and equipment | ($285k) | ($245k) | ($1.9m) | ($1.7m) | ($147k) | $0 | $0 | ($9.4m) | |
| Accretion of discount on marketable securities, net | ($441k) | $197k | $4.3m | $3.1m | ($5.2m) | ($11.7m) | ($7.6m) | — | |
| Purchases of marketable securities | ($79.1m) | ($78.9m) | ($1.3b) | ($190.6m) | ($472.9m) | ($675.6m) | ($389.2m) | — | |
| Maturities of marketable securities | $70.3m | $40.5m | $47.9m | $83.1m | $435.2m | $635.4m | $561.4m | — | |
| Sales of marketable securities | $0 | $0 | $633.8m | $107.2m | $74.7m | $17.4m | $10.4m | — | |
| Net cash provided by (used in) investing activities | ($13.1m) | ($70.4m) | ($640.6m) | ($59.9m) | $31.2m | ($29.3m) | $147.2m | $257.5m | |
| Proceeds from issuance of common stock upon exercise of stock options and common stock warrants | — | $8.9m | $12.6m | $9.9m | $12.9m | $19.7m | $9.8m | — | |
| Proceeds from issuance of common stock in connection with the employee stock purchase plan | $0 | $0 | $1.4m | $4.8m | $3.4m | $3.6m | $3.9m | — | |
| Repurchase of common stock | $0 | ($2.0m) | ($2.7m) | ($85.3m) | ($280.7m) | ($120.3m) | ($431.7m) | — | |
| Taxes paid related to net share settlement of equity awards | $0 | $0 | ($817k) | ($3.8m) | ($6.8m) | ($27.2m) | ($40.8m) | — | |
| Net cash used in financing activities | $1.7m |
$5.4m
+214.54%
|
$560.4m
+10264.62%
|
($74.5m)
-113.29%
|
($276.5m)
-271.37%
|
($131.1m)
+52.58%
|
($464.1m)
-253.87%
|
($427.5m)
+7.88%
|
|
| Net increase (decrease) in cash and cash equivalents | $14.8m | $18.0m | $46.4m | $45.2m | ($61.2m) | $112.8m | $9.6m | — | |
| Cash and cash equivalents, beginning of period | $48.4m | $66.4m | $112.8m | $158.0m | $96.8m | $209.6m | $219.2m | — | |
| Additional Supplementary Disclosures | |||||||||
| Additional Supplementary Disclosures | |||||||||
| Non-cash lease expense | $2.0m | $2.4m | $1.2m | $2.0m | $2.1m | $1.8m | $1.7m | — | |
| Deferred contract costs | ($5.7m) | ($9.4m) | ($9.6m) | ($8.5m) | ($8.6m) | ($12.1m) | ($14.5m) | — | |
| Operating lease liabilities | ($3.9m) | ($2.6m) | ($1.1m) | ($213k) | ($1.7m) | ($2.1m) | ($2.2m) | — | |
| Cash paid for acquisition, net of cash acquired | $0 | ($31.7m) | $0 | ($53.5m) | $0 | $0 | ($26.5m) | — | |
| Purchases of intangible assets | — | — | — | — | $0 | $0 | ($62k) | — | |
| Internal-use software development costs | ($4.0m) | ($4.4m) | ($3.8m) | ($4.5m) | ($5.7m) | ($6.5m) | ($8.9m) | — | |
| Payment of contingent consideration related to a business combination | — | — | $0 | $0 | ($5.4m) | ($5.5m) | ($5.2m) | — | |
| Payment of excise taxes on share repurchases | — | — | — | $0 | $0 | ($1.5m) | $0 | — | |
| Cash paid for taxes, net of refunds | $1.2m | $6.0m | $206k | $5.2m | $51.3m | $55.7m | $21.8m | — | |
| Equity awards included in purchase consideration | — | — | — | — | $0 | $0 | $9.6m | — | |
| Excise tax payable on share repurchases | — | — | $0 | $0 | $1.5m | $0 | $2.3m | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.